SEPARATIVE is an industrial startup located in the heart of the “Chemical Valley” in France, surrounded by major pharmaceutical and chemical companies. It designs, develops and manufactures a breakthrough multi capillary material that solves problems related to purification in the pharmaceutical and chemical industries. The company has obtained 5 patents for the material and its manufacturing process. Separative chromatography column, SEP43, is the first to meet the industry need to purify molecules to high purity quickly and at low pressure. Purification is key for all chemical industries. Yet, current techniques are expensive, slow, energy-intensive, and create issues for health, safety and the environment. Hence, purification has become a lock-in drug discovery. SEP43 would enable faster drug and chemical development, at a lower cost, with a safer and more eco-friendly manufacturing process. This is in line with the European Green Deal as the use of the product would save up to 20,000 mt of CO2E from solvent incineration, 8000kw/h electricity consumption and solvent cost of €9.6M/year. SEPARATIVE's prototypes have been successfully tested at TRL6 by independent laboratories.
- Invested amount
- Engineering and technology